Caterina Veroni

1.4k total citations
24 papers, 994 citations indexed

About

Caterina Veroni is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Caterina Veroni has authored 24 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Caterina Veroni's work include Multiple Sclerosis Research Studies (10 papers), Polyomavirus and related diseases (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Caterina Veroni is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Polyomavirus and related diseases (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Caterina Veroni collaborates with scholars based in Italy, Malta and United Kingdom. Caterina Veroni's co-authors include Francesca Aloisi, Barbara Serafini, Barbara Rosicarelli, Angela Maselli, Marina Pierdominici, Elena Ortona, Yehuda Shoenfeld, Roberta Magliozzi, Richard Reynolds and Eliana M. Coccia and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and Neurology.

In The Last Decade

Caterina Veroni

23 papers receiving 978 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caterina Veroni Italy 17 391 334 205 193 171 24 994
Assunta Bianco Italy 18 382 1.0× 295 0.9× 140 0.7× 259 1.3× 155 0.9× 36 977
Michael Cossoy Canada 11 418 1.1× 214 0.6× 212 1.0× 212 1.1× 186 1.1× 11 951
Rodrigo Naves Chile 17 390 1.0× 628 1.9× 243 1.2× 245 1.3× 204 1.2× 31 1.2k
Giorgia Teresa Maniscalco Italy 15 447 1.1× 438 1.3× 159 0.8× 277 1.4× 84 0.5× 64 1.1k
Judith Fraussen Belgium 17 355 0.9× 554 1.7× 115 0.6× 204 1.1× 113 0.7× 28 1.1k
Begoña Oliver‐Martos Spain 17 262 0.7× 287 0.9× 188 0.9× 229 1.2× 102 0.6× 63 959
Raphaël Schneider Canada 15 191 0.5× 302 0.9× 181 0.9× 284 1.5× 100 0.6× 54 961
Taissa M. Kasahara Brazil 19 300 0.8× 414 1.2× 91 0.4× 140 0.7× 111 0.6× 33 846
Darius Matusevičius Sweden 17 445 1.1× 791 2.4× 268 1.3× 245 1.3× 224 1.3× 27 1.4k
Elisabetta Zardini Italy 19 442 1.1× 180 0.5× 134 0.7× 220 1.1× 117 0.7× 43 1.1k

Countries citing papers authored by Caterina Veroni

Since Specialization
Citations

This map shows the geographic impact of Caterina Veroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caterina Veroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caterina Veroni more than expected).

Fields of papers citing papers by Caterina Veroni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caterina Veroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caterina Veroni. The network helps show where Caterina Veroni may publish in the future.

Co-authorship network of co-authors of Caterina Veroni

This figure shows the co-authorship network connecting the top 25 collaborators of Caterina Veroni. A scholar is included among the top collaborators of Caterina Veroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caterina Veroni. Caterina Veroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lanciotti, Angela, Maria Stefania Brignone, Chiara De Nuccio, et al.. (2025). Astrocytes differentiated from patient iPSCs model the rare leukodystrophy MLC and uncover disease-linked maturation defects and Kir4.1 channel dysfunction. Neurobiology of Disease. 218. 107218–107218.
2.
Veroni, Caterina, Stefania Olla, Maria Stefania Brignone, et al.. (2024). The Antioxidant Drug Edaravone Binds to the Aryl Hydrocarbon Receptor (AHR) and Promotes the Downstream Signaling Pathway Activation. Biomolecules. 14(4). 443–443. 2 indexed citations
3.
Orlando, Biagio, Alessandra Morano, Emanuele Cerulli Irelli, et al.. (2023). Plasma Biomarker Profile and Clinical Correlations in Adult Patients With Tuberous Sclerosis Complex. Neurology. 101(19). e1933–e1938. 2 indexed citations
4.
Colombo, Eleonora, Stefania Olla, Cristina Minnelli, et al.. (2023). Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic Probes. Molecules. 28(19). 6928–6928. 2 indexed citations
5.
Piscopo, Paola, Roberto Rivabene, Alessio Crestini, et al.. (2022). A Plasma Circular RNA Profile Differentiates Subjects with Alzheimer’s Disease and Mild Cognitive Impairment from Healthy Controls. International Journal of Molecular Sciences. 23(21). 13232–13232. 18 indexed citations
6.
Veroni, Caterina & Francesca Aloisi. (2021). The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis. Frontiers in Immunology. 12. 665718–665718. 43 indexed citations
7.
Veroni, Caterina, Barbara Serafini, Barbara Rosicarelli, et al.. (2020). Connecting Immune Cell Infiltration to the Multitasking Microglia Response and TNF Receptor 2 Induction in the Multiple Sclerosis Brain. Frontiers in Cellular Neuroscience. 14. 190–190. 15 indexed citations
8.
Agresti, Cristina, Rosella Mechelli, Stefania Olla, et al.. (2019). Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of Edaravone. Current Medicinal Chemistry. 27(13). 2095–2105. 5 indexed citations
9.
Brignone, Maria Stefania, Angela Lanciotti, Barbara Serafini, et al.. (2019). Megalencephalic Leukoencephalopathy with Subcortical Cysts Protein-1 (MLC1) Counteracts Astrocyte Activation in Response to Inflammatory Signals. Molecular Neurobiology. 56(12). 8237–8254. 19 indexed citations
10.
Veroni, Caterina, Barbara Serafini, Barbara Rosicarelli, Corrado Fagnani, & Francesca Aloisi. (2018). Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis. Journal of Neuroinflammation. 15(1). 18–18. 63 indexed citations
11.
Serafini, Barbara, Stéphanie Zandee, Barbara Rosicarelli, et al.. (2018). Epstein-Barr virus-associated immune reconstitution inflammatory syndrome as possible cause of fulminant multiple sclerosis relapse after natalizumab interruption. Journal of Neuroimmunology. 319. 9–12. 17 indexed citations
12.
Olla, Stefania, Caterina Veroni, Renato Umeton, et al.. (2017). A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials. Scientific Reports. 7(1). 45780–45780. 30 indexed citations
13.
Serafini, Barbara, Barbara Rosicarelli, Caterina Veroni, et al.. (2016). RORγt Expression and Lymphoid Neogenesis in the Brain of Patients with Secondary Progressive Multiple Sclerosis. Journal of Neuropathology & Experimental Neurology. 75(9). 877–888. 32 indexed citations
14.
Lanciotti, Angela, Maria Stefania Brignone, Sergio Visentin, et al.. (2016). Megalencephalic leukoencephalopathy with subcortical cysts protein-1 regulates epidermal growth factor receptor signaling in astrocytes. Human Molecular Genetics. 25(8). 1543–1558. 27 indexed citations
15.
Veroni, Caterina, Fabiana Marnetto, Letizia Granieri, et al.. (2015). Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis. Journal of Neuroinflammation. 12(1). 132–132. 21 indexed citations
16.
Magliozzi, Roberta, Barbara Serafini, Barbara Rosicarelli, et al.. (2012). B-Cell Enrichment and Epstein-Barr Virus Infection in Inflammatory Cortical Lesions in Secondary Progressive Multiple Sclerosis. Journal of Neuropathology & Experimental Neurology. 72(1). 29–41. 92 indexed citations
17.
Veroni, Caterina, Lucia Gabriele, Irene Canini, et al.. (2010). Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways. Molecular and Cellular Neuroscience. 45(3). 234–244. 88 indexed citations
18.
Serafini, Barbara, Martina Severa, Sandra Columba‐Cabezas, et al.. (2010). Epstein-Barr Virus Latent Infection and BAFF Expression in B Cells in the Multiple Sclerosis Brain: Implications for Viral Persistence and Intrathecal B-Cell Activation. Journal of Neuropathology & Experimental Neurology. 69(7). 677–693. 128 indexed citations
19.
Veroni, Caterina, Margherita Grasso, Gianfranco Macchia, et al.. (2007). β‐dystrobrevin, a kinesin‐binding receptor, interacts with the extracellular matrix components pancortins. Journal of Neuroscience Research. 85(12). 2631–2639. 22 indexed citations
20.
Ceccarini, Marina, Margherita Grasso, Caterina Veroni, et al.. (2007). Association of Dystrobrevin and Regulatory Subunit of Protein Kinase A: A New Role for Dystrobrevin as a Scaffold for Signaling Proteins. Journal of Molecular Biology. 371(5). 1174–1187. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026